|Salary:||£36,386 to £42,155 per annum|
|Placed On:||1st February 2023|
|Closes:||28th February 2023|
We are seeking a highly motivated postdoctoral researcher to join the group of Dr. Ian Copple and address knowledge gaps related to the therapeutic targeting of the Nrf2 pathway in diseases associated with oxidative stress. The successful candidate will (1) establish a human in vitro model of non-alcoholic steatohepatitis (NASH) for use in drug screening studies, and (2) generate in vitro stimulated human blood samples for ‘omics analysis by project partners.
Experience in cell culture and analysis of gene/protein expression is essential. Ideally, you will also have experience of (1) isolation/culture of human primary liver cells, (2) 3D cell culture techniques, (3) handling human blood, including preparation of peripheral blood mononuclear cells, (4) experience of analysing ‘omics data sets. You should have a PhD (or be about to obtain) in a relevant life science or biomedical subject.
Any applicants who are still awaiting their PhD to be awarded should be aware that if successful, they will be appointed at grade 6, spine point 30. Upon written confirmation that they have been successful in being awarded their PhD, they will be moved onto grade 7, spine point 31 from the date of their award.
The post is funded by the MRC and is available on a fixed term basis until 31st March 2025.
Interviews are anticipated to take place in March 2023.
Pre-application enquiries are encouraged – please contact Dr. Ian Copple: email@example.com
For full details and to apply online, please visit: recruit.liverpool.ac.uk
Type / Role: